Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genomics and drug profiling of fatal TCF3-HLF−positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options
Ute Fischer, Michael Förster, Anna Maria Rinaldi, et al.
Nature Genetics (2015) Vol. 47, Iss. 9, pp. 1020-1029
Open Access | Times Cited: 219

Showing 1-25 of 219 citing articles:

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms
Rita Alaggio, Catalina Amador, Ioannis Anagnostopoulos, et al.
Leukemia (2022) Vol. 36, Iss. 7, pp. 1720-1748
Open Access | Times Cited: 2321
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
Daniel A. Arber, Attilio Orazi, Robert P. Hasserjian, et al.
Blood (2022) Vol. 140, Iss. 11, pp. 1200-1228
Open Access | Times Cited: 1676
Pediatric acute lymphoblastic leukemia
Hiroto Inaba, Charles G. Mullighan
Haematologica (2020) Vol. 105, Iss. 11, pp. 2524-2539
Open Access | Times Cited: 534
Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia
Henrik Lilljebjörn, Rasmus Henningsson, Axel Hyrenius‐Wittsten, et al.
Nature Communications (2016) Vol. 7, Iss. 1
Open Access | Times Cited: 278
Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases
Jianfeng Li, Yuting Dai, Henrik Lilljebjörn, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 50
Open Access | Times Cited: 252
IKZF1plusDefines a New Minimal Residual Disease–Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia
Martin Stanulla, Elif Dağdan, Markéta Žaliová, et al.
Journal of Clinical Oncology (2018) Vol. 36, Iss. 12, pp. 1240-1249
Open Access | Times Cited: 250
Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemia
Viktoras Frismantas, Maria Pamela Dobay, Anna Maria Rinaldi, et al.
Blood (2017) Vol. 129, Iss. 11, pp. e26-e37
Open Access | Times Cited: 212
ZNF384 -related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype
Shinsuke Hirabayashi, Kentaro Ohki, Kazuhiko Nakabayashi, et al.
Haematologica (2016) Vol. 102, Iss. 1, pp. 118-129
Open Access | Times Cited: 197
Advances in the Diagnosis and Treatment of Pediatric Acute Lymphoblastic Leukemia
Hiroto Inaba, Ching‐Hon Pui
Journal of Clinical Medicine (2021) Vol. 10, Iss. 9, pp. 1926-1926
Open Access | Times Cited: 163
Pediatric Acute Lymphoblastic Leukemia, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
Patrick A. Brown, Hiroto Inaba, Colleen Annesley, et al.
Journal of the National Comprehensive Cancer Network (2020) Vol. 18, Iss. 1, pp. 81-112
Open Access | Times Cited: 162
International Consensus Classification of acute lymphoblastic leukemia/lymphoma
Amy S. Duffield, Charles G. Mullighan, Michael J. Borowitz
Virchows Archiv (2022) Vol. 482, Iss. 1, pp. 11-26
Open Access | Times Cited: 87
Pharmacotypes across the genomic landscape of pediatric acute lymphoblastic leukemia and impact on treatment response
Shawn H. R. Lee, Wenjian Yang, Yoshihiro Gocho, et al.
Nature Medicine (2023) Vol. 29, Iss. 1, pp. 170-179
Open Access | Times Cited: 54
Acute lymphoblastic leukaemia
Luca Pagliaro, Sai‐Juan Chen, Daniel Herranz, et al.
Nature Reviews Disease Primers (2024) Vol. 10, Iss. 1
Closed Access | Times Cited: 44
Venetoclax responses of pediatric ALL xenografts reveal sensitivity of MLL-rearranged leukemia
Seong Lin Khaw, Santi Suryani, Kathryn Evans, et al.
Blood (2016) Vol. 128, Iss. 10, pp. 1382-1395
Open Access | Times Cited: 161
Genetics and prognosis of ALL in children vs adults
Kathryn G. Roberts
Hematology (2018) Vol. 2018, Iss. 1, pp. 137-145
Open Access | Times Cited: 150
Precision medicine in acute lymphoblastic leukemia
Ching‐Hon Pui
Frontiers of Medicine (2020) Vol. 14, Iss. 6, pp. 689-700
Open Access | Times Cited: 112
Activation of concurrent apoptosis and necroptosis by SMAC mimetics for the treatment of refractory and relapsed ALL
Scott McComb, Júlia Aguadé-Gorgorió, Lena Harder, et al.
Science Translational Medicine (2016) Vol. 8, Iss. 339
Closed Access | Times Cited: 106
Venetoclax: evidence to date and clinical potential
Luis Miguel Juárez‐Salcedo, Viraj Desai, Samir Dalia
Drugs in Context (2019) Vol. 8, pp. 1-13
Open Access | Times Cited: 106
RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia
Isabel S. Jerchel, Alex Q. Hoogkamer, Ingrid M. Ariës, et al.
Leukemia (2017) Vol. 32, Iss. 4, pp. 931-940
Open Access | Times Cited: 96
New Approaches to the Management of Adult Acute Lymphoblastic Leukemia
Renato Bassan, Jean‐Pierre Bourquin, Daniel J. DeAngelo, et al.
Journal of Clinical Oncology (2018) Vol. 36, Iss. 35, pp. 3504-3519
Open Access | Times Cited: 89
Next-Generation Sequencing in Acute Lymphoblastic Leukemia
Nicoletta Coccaro, Luisa Anelli, Antonella Zagaria, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 12, pp. 2929-2929
Open Access | Times Cited: 86
The application of RNA sequencing for the diagnosis and genomic classification of pediatric acute lymphoblastic leukemia
Lauren M. Brown, Andrew Lonsdale, Andrea Zhu, et al.
Blood Advances (2020) Vol. 4, Iss. 5, pp. 930-942
Open Access | Times Cited: 76
Biologic and Therapeutic Implications of Genomic Alterations in Acute Lymphoblastic Leukemia
Ilaria Iacobucci, Shunsuke Kimura, Charles G. Mullighan
Journal of Clinical Medicine (2021) Vol. 10, Iss. 17, pp. 3792-3792
Open Access | Times Cited: 75
DYRK1A regulates B cell acute lymphoblastic leukemia through phosphorylation of FOXO1 and STAT3
Rahul S. Bhansali, Malini Rammohan, Paul Lee, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 1
Open Access | Times Cited: 68
Genetic Biomarkers and Their Clinical Implications in B-Cell Acute Lymphoblastic Leukemia in Children
Monika Lejman, Aleksandra Chałupnik, Zuzanna Chilimoniuk, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2755-2755
Open Access | Times Cited: 55
Page 1 - Next Page

Scroll to top